People

The Journal of Aerosol Medicine and Pulmonary Drug Delivery, the official journal of the International Society for Aerosols in Medicine (ISAM), has announced that GSK VP US Medical and Therapy Head for Respiratory Thomas G. O’Riordan will take over as Editor-in-Chief as of March 1, 2022. His predecessor, Gerry Smaldone, announced in October 2021 that he would step … [Read more...] about Thomas G. O’Riordan named Editor-in-Chief of the Journal of Aerosol Medicine and Pulmonary Drug Delivery

Gilbert Technologies, which is developing a soft mist inhaler device based on electrohydrodynamic atomization technology, announced that Scott Fleming will take on the role of Chief Commercial Officer. Fleming, who has been the company's Technology Director for the past two years, has extensive experience in OINDPs. A co-founder of inhaled drug developer Microdose … [Read more...] about Gilbert Technologies names Scott Fleming Chief Commercial Officer

CDMO Hovione has announced that Jean-Luc Herbeaux will succeed Guy Villax as CEO of Hovione as of April 1, 2022. Herbeaux joined Hovione as Chief Operating Officer in 2020 after having served in various executive roles at Evonik. Villax will remain a member of the company's board of directors. According to the announcement, the company, which offers inhalation … [Read more...] about Jean-Luc Herbeaux to succeed Guy Villax as Hovione CEO

The International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) has announced that Kindeva Drug Delivery Global Respiratory Product Development Manager Mike Needham will serve as Vice Chair of the IPAC-RS board until June 1, 2022 and will then take over as Chair, succeeding Carla Vozone of Catalent Pharma Solutions who will become Chair … [Read more...] about IPAC-RS announces board changes

ReCode Therapeutics, which recently raised $80 million for development of inhaled genetic therapies for cystic fibrosis and primary ciliary dyskinesia (PCD), has announced the appointment of former Theravance Biopharma executive Shehnaaz Suliman as CEO and a member of the company's board of directors. She succeeds David Lockhart as CEO; Lockhart will continue as … [Read more...] about ReCode Therapeutics names Shehnaaz Suliman as CEO

DPI developer PureIMS has announced the appointment of Jaap Wieling as Chief Executive Officer (CEO), succeeding Bram Van Dijck. According to his LinkedIn page, Wieling founded or co-founded several biopharm companies, including Bioralix, BiosanaPharma, and Antaeus Biopharma, over the past few years. He spent much of his career at Xendo, which he also co-founded. … [Read more...] about Jaap Wieling appointed CEO of PureIMS

Inhaled nitric oxide developer Beyond Air announced that pulmonologist Andrew Colin has been appointed as the company's Chief Medical Officer, effective December 1, 2021. Colin, who was most recently Chief of the Division of Pediatric Pulmonology at the University of Miami's Miller School of Medicine and Director of the university's Cystic Fibrosis Center, has … [Read more...] about Andrew Colin joins Beyond Air as Chief Medical Officer

Device developer Cambridge Healthcare Innovations (CHI) has announced the appointment of former AuroScience Head of Device Development Philip Canner as CEO. In addition to AuroScience, an Aurobindo subsidiary that develops generic inhaled drugs, Canner's OINDP development experience also includes a stint at Team Consulting. Earlier this year, CHI partnered with … [Read more...] about Philip Canner joins Cambridge Healthcare Innovations as CEO